Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Phyllis M. Salzman"'
Autor:
Robert D. McQuade, William H. Carson, Phyllis M. Salzman, Eva Kohegyi, Margaretta Nyilas, Christoph U. Correll, Raymond Sanchez, Ross A. Baker, Cathy Zhao
Publikováno v:
Journal of the American Academy of Child and Adolescent Psychiatry. 56(9)
Objective To evaluate the efficacy, safety, and tolerability of aripiprazole, a dopamine D 2 receptor partial agonist, as maintenance treatment in adolescent outpatients with schizophrenia. Method This was a multicenter, double-blind, placebo-control
Autor:
Peter Hertel, Pamela Perry, Robert D. McQuade, N. Jin, Phyllis M. Salzman, William H. Carson, Pedro Such, Margaretta Nyilas, Kevin Cox, Joan Amatniek, Raymond Sanchez, Joseph R. Calabrese, B. Johnson
Publikováno v:
The Journal of clinical psychiatry. 78(3)
To evaluate efficacy, safety, and tolerability of long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (AOM 400) as maintenance treatment for bipolar I disorder (BP-I).In a double-blind, placebo-controlled, 52-week randomized withdra
Autor:
Robert D. McQuade, Pamela Perry, B. Johnson, Anna Eramo, Cathy Zhao, Timothy Peters-Strickland, Phyllis M. Salzman, Raymond Sanchez
Publikováno v:
CNS spectrums. 21(6)
ObjectiveTo assess the effects of aripiprazole once-monthly 400 mg (AOM 400) on clinical symptoms and global improvement in schizophrenia after switching from an oral antipsychotic.MethodsIn a multicenter, open-label, mirror-image, naturalistic study
Autor:
Ronald E, Wilson, Lauren C, Seeberger, Dee, Silver, Alida, Griffith, Jill B, Conner, Phyllis M, Salzman, Jim, Strom
Publikováno v:
The Neurologist. 17:318-324
Objective Rasagiline, a monoamine oxidase type B inhibitor, is indicated for both the initial treatment of Parkinson disease (PD) and as adjunctive (add-on) treatment for patients already taking dopaminergic therapy. This open-label prospective commu
Publikováno v:
The Journal of Urology. :2427-2431
Purpose: We confirmed findings that oral desmopressin safely decreases the number of wet nights in children with enuresis and identified doses at which acceptable responses can be obtained.Materials and Methods: We evaluated the safety and efficacy o
Autor:
Edward D. Gomperts, Robert M Montgomery, R. Miller, Hugh C. Kim, Kenneth J. Smith, Carol K. Kasper, Phyllis M Salzman, Diane Tipping
Publikováno v:
Thrombosis and Haemostasis. 66:730-733
SummaryIn response to reports of discrepant in vitro assays of high-purity concentrates, a double-blind crossover study of in vivo recovery and half-life of two brands of monoclonal-antibody-purified factor VIII concentrates (Monoclate and Hemofil-M)
Autor:
Susan K Brown, Hugh M Davis, David W Nash, Alian B Schreiber, Phyllis M Salzman, Aniello M Pennetti, Joseph Haimovich
Publikováno v:
Thrombosis and Haemostasis. 63:386-391
SummaryHemophilia A is caused by factor VIII deficiency that historically has been treated with either a cryoprecipitate fraction of serum or factor VIII concentrate. Recently, the availability of affinity isolated factor VIII (Monoclate®) has allow
Publikováno v:
Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2(3)
This study had two main objectives: 1. To enable patients with amyotrophic lateral sclerosis (ALS) who had not participated in previous riluzole trials to receive riluzole therapy, and 2. To expand safety experience with the drug in a broad patient p
Publikováno v:
Biochemical Pharmacology. 23:2779-2784
Autor:
Robert H. Roth, Phyllis M. Salzman
Publikováno v:
Progress in Neurobiology. 13:1-60